FI98891B - Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi - Google Patents

Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi

Info

Publication number
FI98891B
FI98891B FI904618A FI904618A FI98891B FI 98891 B FI98891 B FI 98891B FI 904618 A FI904618 A FI 904618A FI 904618 A FI904618 A FI 904618A FI 98891 B FI98891 B FI 98891B
Authority
FI
Finland
Prior art keywords
raising
procedure
aqueous solution
protein content
protein
Prior art date
Application number
FI904618A
Other languages
English (en)
Swedish (sv)
Other versions
FI98891C (fi
FI904618A0 (fi
Inventor
Yukio Shimazaki
Nobuhiro Kawashima
Miki Yoshioka
Yasuhito Tanaka
Ryo Tanaka
Kiyoshi Sakai
Hisahiro Ishiwari
Original Assignee
Mitsui Toatsu Chemicals
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals, Mochida Pharm Co Ltd filed Critical Mitsui Toatsu Chemicals
Publication of FI904618A0 publication Critical patent/FI904618A0/fi
Application granted granted Critical
Publication of FI98891B publication Critical patent/FI98891B/fi
Publication of FI98891C publication Critical patent/FI98891C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI904618A 1989-09-21 1990-09-19 Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi FI98891C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1243311A JPH0791318B2 (ja) 1989-09-21 1989-09-21 蛋白質水溶液、蛋白質水溶液の濃度増大方法および蛋白質製剤
JP24331189 1989-09-21

Publications (3)

Publication Number Publication Date
FI904618A0 FI904618A0 (fi) 1990-09-19
FI98891B true FI98891B (fi) 1997-05-30
FI98891C FI98891C (fi) 1997-09-10

Family

ID=17101947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904618A FI98891C (fi) 1989-09-21 1990-09-19 Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi

Country Status (14)

Country Link
EP (1) EP0419251B1 (fi)
JP (1) JPH0791318B2 (fi)
KR (1) KR930004598B1 (fi)
CN (1) CN1049356C (fi)
AT (1) ATE93731T1 (fi)
AU (1) AU627621B2 (fi)
BR (1) BR9004693A (fi)
CA (1) CA2025315C (fi)
DE (1) DE69003061T2 (fi)
DK (1) DK0419251T3 (fi)
ES (1) ES2060057T3 (fi)
FI (1) FI98891C (fi)
NO (1) NO904120L (fi)
NZ (1) NZ235297A (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1602667E (pt) * 1995-06-07 2007-07-13 Searle Llc Formulação aquosa que compreende tfpi e agentes de solubilização
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
BRPI0809209A2 (pt) 2007-03-29 2014-09-02 Abbott Lab Anticorpos il-12 anti-humanos cristalinos
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107185A (en) * 1981-10-07 1983-04-27 John Kenneth Mcmullen Insulin formulations containing surface-active agents
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
JPS61289886A (ja) * 1985-06-19 1986-12-19 Agency Of Ind Science & Technol 酵素及び／又は微生物含有アルギン酸繊維紙の製造法
CA1292686C (en) * 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH02111726A (ja) * 1988-10-19 1990-04-24 Dainippon Pharmaceut Co Ltd ヒト　インターロイキン１を安定化する方法

Also Published As

Publication number Publication date
BR9004693A (pt) 1991-09-10
CA2025315C (en) 1997-01-07
EP0419251A1 (en) 1991-03-27
EP0419251B1 (en) 1993-09-01
DE69003061D1 (de) 1993-10-07
KR930004598B1 (ko) 1993-06-01
ATE93731T1 (de) 1993-09-15
AU6246690A (en) 1991-03-28
JPH03106898A (ja) 1991-05-07
CN1050327A (zh) 1991-04-03
AU627621B2 (en) 1992-08-27
ES2060057T3 (es) 1994-11-16
DE69003061T2 (de) 1993-12-16
KR910005884A (ko) 1991-04-27
DK0419251T3 (da) 1994-01-31
CA2025315A1 (en) 1991-03-22
NO904120D0 (no) 1990-09-20
FI98891C (fi) 1997-09-10
FI904618A0 (fi) 1990-09-19
CN1049356C (zh) 2000-02-16
NZ235297A (en) 1992-12-23
JPH0791318B2 (ja) 1995-10-04
NO904120L (no) 1991-03-22

Similar Documents

Publication Publication Date Title
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
NO875299L (no) Insulinpreparat for ikke-paranteral administrasjon.
ES2132066T3 (es) Procedimiento para la produccion de proteina biologicamente activa (v.g. tfg).
ATE66140T1 (de) Salbengrundlage und salbe.
ES2037136T3 (es) Procedimiento para la preparacion de una solucion con elevada actividad volumetrica de una proteina con actividad de activador de plasminogeno de tejidos (t-pa).
SE8505048L (sv) Nutritionsemulsion med syretransporterande egenskaper
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
DE69111205D1 (de) Stabilisierung von Calcitonin enthaltenden pharmazeutischen Verbindungen.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
FI98891B (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
JPS57193494A (en) Method of purifying or concentrating biologically active protein and drug therefor
ATE104149T1 (de) Dialysier- und spuelloesung zur intraperitonealen verarbreichung.
DK0419252T3 (da) Trombolytisk sammensætning indeholdende vævstypeplasmonogenaktivator eller et derivat heraf
DE68902223D1 (de) Waesserige loesungen von doxorubicin.
BG31214A3 (en) Method for obtaining of human albumine
NO862740D0 (no) Fremgangsmaate for stabilisering av xantangummi i vandig loesning.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: MITSUI CHEMICALS, INC.

MM Patent lapsed

Owner name: MITSUI CHEMICALS, INC.